Laurie Smith

1.9k total citations
73 papers, 1.3k citations indexed

About

Laurie Smith is a scholar working on Epidemiology, Oncology and Surgery. According to data from OpenAlex, Laurie Smith has authored 73 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 57 papers in Epidemiology, 32 papers in Oncology and 21 papers in Surgery. Recurrent topics in Laurie Smith's work include Cervical Cancer and HPV Research (55 papers), Global Cancer Incidence and Screening (32 papers) and Genital Health and Disease (20 papers). Laurie Smith is often cited by papers focused on Cervical Cancer and HPV Research (55 papers), Global Cancer Incidence and Screening (32 papers) and Genital Health and Disease (20 papers). Laurie Smith collaborates with scholars based in Canada, United States and Uganda. Laurie Smith's co-authors include Gina Ogilvie, Mel Krajden, Andrew J. Coldman, Eduardo L. Franco, Darrel Cook, Dirk van Niekerk, Kathy Ceballos, Stuart Peacock, Gavin Stuart and Lovedeep Gondara and has published in prestigious journals such as JAMA, Nature Medicine and SHILAP Revista de lepidopterología.

In The Last Decade

Laurie Smith

72 papers receiving 1.3k citations

Peers

Laurie Smith

EPIDE

ONCOL

SURGE

HEALT

Raúl Murillo Colombia

Inge M.C.M. de Kok Netherlands

C. Sarai Racey Canada

Bengt Andrae Sweden

Virginia Senkomago United States

Rosa Catarino Switzerland

Amy E. Pollack United States

Michelle I. Silver United States

Louise Cadman United Kingdom

Maurício Maza United States

Raúl Murillo Colombia

Laurie Smith

1.2k ×1.1

EPIDE

1.0k ×2.1

ONCOL

437 ×1.3

SURGE

120 ×0.7

HEALT

133 ×0.9

Citations per year, relative to Laurie Smith Laurie Smith (= 1×) peers Raúl Murillo

Countries citing papers authored by Laurie Smith

Since Specialization

Citations

This map shows the geographic impact of Laurie Smith's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Laurie Smith with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Laurie Smith more than expected).

Fields of papers citing papers by Laurie Smith

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Laurie Smith. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Laurie Smith. The network helps show where Laurie Smith may publish in the future.

Co-authorship network of co-authors of Laurie Smith

This figure shows the co-authorship network connecting the top 25 collaborators of Laurie Smith. A scholar is included among the top collaborators of Laurie Smith based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Laurie Smith. Laurie Smith is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Smith, Laurie, Amy Booth, C. Sarai Racey, et al.. (2024). Self-Screening for Cervical Cancer Offered through a Digital Platform in a Region of British Columbia with Lower Screening Rates. Current Oncology. 31(9). 5399–5411. 1 indexed citations

Gottschlich, Anna, Quan Hong, Lovedeep Gondara, et al.. (2024). Evidence of Decreased Long-term Risk of Cervical Precancer after Negative Primary HPV Screens Compared with Negative Cytology Screens in a Longitudinal Cohort Study. Cancer Epidemiology Biomarkers & Prevention. 33(7). 904–911. 1 indexed citations

Gottschlich, Anna, Laurie Smith, Lily Proctor, & Gina Ogilvie. (2024). HPV Extended Genotyping to Triage Abnormal Cervical Cancer Screens—Balancing the Harms and Benefits of an Additional Triage Test before Direct Colposcopy Referral. Cancer Epidemiology Biomarkers & Prevention. 33(8). 979–981.

Tatar, Ovidiu, Samara Perez, Julia Brotherton, et al.. (2024). On the path toward cervical cancer elimination in Canada: a national survey of factors influencing women's intentions to participate in human papillomavirus test-based primary cervical screening. The Lancet Regional Health - Americas. 39. 100901–100901. 4 indexed citations

Dau, Hallie, Amy Booth, Laurie Smith, et al.. (2024). Investigating the healthcare‐seeking behaviors of mobile phone users to improve cervical cancer screening in rural Uganda. International Journal of Gynecology & Obstetrics. 167(1). 223–229. 1 indexed citations

Donken, Robine, Gina Ogilvie, Laurie Smith, et al.. (2023). Age-Specific Trends of Invasive Cervical Cancer Incidence in British Columbia, Canada, 1971–2017. Current Oncology. 30(8). 7692–7705. 5 indexed citations

Gottschlich, Anna, Lovedeep Gondara, Laurie Smith, et al.. (2023). Colposcopy referral rates post-introduction of primary screening with human papillomavirus testing: evidence from a large British Columbia cohort study. The Lancet Regional Health - Americas. 26. 100598–100598. 3 indexed citations

Dau, Hallie, Beth A. Payne, Marianne Vidler, et al.. (2023). The burden of travelling for cervical cancer treatment in Uganda: A mixed‐method study. Tropical Medicine & International Health. 29(2). 137–143. 2 indexed citations

Dau, Hallie, et al.. (2023). The barriers to cervical cancer screening for urban and rural populations in Rwanda. PubMed. 1(1). 4–4. 1 indexed citations

10.

Brotto, Lori A., Liisa A.M. Galea, Arianne Albert, et al.. (2022). Barriers To Accessing Contraception and Cervical and Breast Cancer Screening During COVID-19: A Prospective Cohort Study. Journal of Obstetrics and Gynaecology Canada. 44(10). 1076–1083. 7 indexed citations

11.

Racey, C. Sarai, Amy Booth, Arianne Albert, et al.. (2022). Seropositivity of SARS-CoV-2 in an unvaccinated cohort in British Columbia, Canada: a cross-sectional survey with dried blood spot samples. BMJ Open. 12(8). e062567–e062567. 4 indexed citations

12.

Sharma, Bhawna, C. Sarai Racey, Amy Booth, et al.. (2022). Characterizing intentions to receive the COVID-19 vaccine among the general population in British Columbia based on their future intentions towards the seasonal influenza vaccine. Vaccine X. 12. 100208–100208. 5 indexed citations

13.

Gottschlich, Anna, Darrel Cook, Laurie Smith, et al.. (2021). Long-term cervical precancer outcomes after a negative DNA- or RNA-based human papillomavirus test result. American Journal of Obstetrics and Gynecology. 225(5). 511.e1–511.e7. 10 indexed citations

14.

Smith, Laurie, Lindsay Hedden, Andrew J. Coldman, et al.. (2021). Cost‐effectiveness analysis of primary human papillomavirus testing in cervical cancer screening: Results from the HPV FOCAL Trial. Cancer Medicine. 10(9). 2996–3003. 14 indexed citations

15.

Smith, Laurie, Dirk van Niekerk, Nadine R. Caron, et al.. (2021). Sociodemographic characteristics of women with invasive cervical cancer in British Columbia, 2004–2013: a descriptive study. CMAJ Open. 9(2). E424–E432. 10 indexed citations

16.

Gottschlich, Anna, Dirk van Niekerk, Laurie Smith, et al.. (2020). Assessing 10-Year Safety of a Single Negative HPV Test for Cervical Cancer Screening: Evidence from FOCAL-DECADE Cohort. Cancer Epidemiology Biomarkers & Prevention. 30(1). 22–29. 16 indexed citations

17.

Coldman, Andrew J., Dirk van Niekerk, Mel Krajden, et al.. (2019). Disease detection at the 48‐month exit round of the HPV FOCAL cervical cancer screening trial in women per‐protocol eligible for routine screening. International Journal of Cancer. 146(7). 1810–1818. 2 indexed citations

18.

Cook, Darrel, Laurie Smith, Jennifer Law, et al.. (2018). Comparative performance of human papillomavirus messenger RNA versus DNA screening tests at baseline and 48 months in the HPV FOCAL trial. Journal of Clinical Virology. 108. 32–37. 15 indexed citations

19.

Ogilvie, Gina, Dirk van Niekerk, Mel Krajden, et al.. (2018). Effect of Screening With Primary Cervical HPV Testing vs Cytology Testing on High-grade Cervical Intraepithelial Neoplasia at 48 Months: The HPV FOCAL Randomized Clinical Trial. Obstetrical & Gynecological Survey. 73(11). 632–634. 32 indexed citations

20.

Cook, Darrel, Mel Krajden, Adam R. Brentnall, et al.. (2018). Evaluation of a validated methylation triage signature for human papillomavirus positive women in the HPV FOCAL cervical cancer screening trial. International Journal of Cancer. 144(10). 2587–2595. 60 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact